DDR on DTC: Vaniqa

Share this article:
DDR on DTC: Vaniqa
DDR on DTC: Vaniqa
Vaniqa is an Rx dermatological cream that reduces “unwanted facial hair” in women. It's a “cosmeceutical” brand that falls somewhere between the dermatologist's office and your local Sephora, and its new DTC campaign is just as confused. We see many happy customers in 60 seconds — all in close-up, too. They may be smiling because they got a $50 rebate, which is prominently displayed a few times.
The ad is very hard working. It uses a clinical tone so we know it's a serious, not frivolous, beauty aid. We see a brief “little science” demo that shows how hair follicle growth is stunted by an enzyme blocker in Vaniqa. And the ad delivers an end-benefit that could apply to any number of personal care products: “the freedom to be close to people.” All in all, it's basically a mini-infomercial, complete with testimonials and offers, but in a 60-second format
Unfortunately, even though a large amount of information is provided, the ad fails to build an emotional connection for the brand. And worse, the call-to-action is fumbled, so we are not sure what to do or where to go for this product. It's too bad the advertising misses an opportunity for Vaniqa to be memorable and wanted by the millions and millions of women who have “unwanted facial hair.” Ouch. My guess is that this is a large female target audience — one that other DTC cosmeceuticals such as Latisse and Oracea have figured out with effective, branded ads that convey both emotion and information.

Deborah Dick-Rath is SVP, healthcare practice leader, at FactorTG. Contact: deborah.dick-rath@factortg.com
Share this article:
You must be a registered member of MMM to post a comment.

Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric